HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Health Catalyst, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.71−0.02 (-0.87%)
Close on Oct 19, 2026
- Market cap
- $126.47M
- P/E (TTM)
- –
- Dividend yield
- –
Health Catalyst, Inc. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Technology | $202.18M | $206.26M | $208.28M | $208.01M | $204.61M | $199.37M | $194.85M | $190.35M | $187.67M | $187.36M | $187.58M | $185.15M | 69.2% | -1.2% |
| Accumulated Impairment Losses | $90.06M | $96.22M | $102.86M | $108.06M | $111.48M | $111.91M | $111.73M | $111.71M | $111.81M | $109.43M | $108.36M | $104.87M | 30.8% | -19.2% |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Technology | $202.18M | $206.26M | $208.28M | $208.01M | $204.61M | $199.37M | $194.85M | $190.35M | $187.67M | $187.36M | $187.58M | $185.15M | 69.2% | -1.2% |
| Recurring technology | $202.18M | $206.26M | $208.28M | $208.01M | $204.61M | $199.37M | $194.85M | $190.35M | $187.67M | $187.36M | $187.23M | $184.89M | 69.2% | -1.2% |
| Accumulated Impairment Losses | $90.06M | $96.22M | $102.86M | $108.06M | $111.48M | $111.91M | $111.73M | $111.71M | $111.81M | $109.43M | $108.36M | $104.87M | 30.8% | -19.2% |
By region
From the segment and revenue-disaggregation notes of Health Catalyst's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.